Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis and bone diseases.
Business Model:
Revenue: $51.9M
Employees: 201-500
Address: 8 Penn Center, 1628 John F. Kennedy Boulevard
City: Philadelphia
State: PA
Zip: 19103-2124
Country: US
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis and bone diseases.
Contact Phone:
+12672737940
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2012 | Series B | 5 | $28M |
Foresite Capital Marker MVM Life Science Partners Novo Holdings Quaker BioVentures Foresite Capital Marker MVM Life Science Partners Novo Holdings Quaker BioVentures |
8/2014 | Debt Financing | 2 | $10M |
Oxford Finance LLC Square 1 Bank Oxford Finance LLC Square 1 Bank |
5/2014 | Series B | $0 |
Foresite Capital MVM Life Science Partners Novo Holdings Quaker Partners Foresite Capital MVM Life Science Partners Novo Holdings Quaker Partners |
1/2010 | Series A | 3 | $24M |
Quaker BioVentures Novo Ventures MVM Life Science Partners |
4/2011 | Debt Financing | $15.5M | 7/2011 | Venture Round | $24.5M | 2/2016 | Debt Financing | $2M | 10/2009 | Venture Round | $12.1M | 7/2017 | Debt | $549.9k | 6/2016 | Debt | $1.3M | 7/2016 | Debt Financing | $1.2M | 12/2016 | Debt | $1.6M | 5/2014 | Series B | 4 | $7M |
Foresite Capital MVM Life Science Partners Novo Holdings Quaker Partners Foresite Capital MVM Life Science Partners Novo Holdings Quaker Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|